|
|
Blood, 1 January 2005, Vol. 105, No. 1, pp. 95-102.
Prepublished online as a Blood First Edition Paper on September 14, 2004; DOI 10.1182/blood-2003-12-4345.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 genetargeted mice
Masahiro Masuya,
Omar Moussa,
Takanori Abe,
Takao Deguchi,
Tsukasa Higuchi,
Yasuhiro Ebihara,
Demetri D. Spyropoulos,
Dennis K. Watson, and
Makio Ogawa
From the Department of Veterans Affairs Medical Center, Charleston SC; and the Departments of Medicine, Pathology and Biochemistry, and Molecular Biology, and the Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
Targeted disruption of the Friend leukemia integration 1 (Fli-1) proto-oncogene results in severe dysmegakaryopoiesis and embryonic lethality. We used morula-stage aggregation as a strategy to further clarify the hematopoietic defects of the Fli-1 gene-targeted mice. Analyses of lineage expression of Fli-1+/- and Fli-1-/- cells in the peripheral blood and bone marrow of chimeric mice consistently demonstrated reduced numbers of neutrophilic granulocytes and monocytes and increased numbers of natural killer (NK) cells. Transplantation studies using sorted Fli-1 mutant cells produced similar findings. Clonal culture studies of bone marrow cells revealed increased numbers of granulocytic and early erythroid progenitors in the Fli-1+/- cells. The sorted Fli-1-/- bone marrow cells revealed specific down-regulation of CCAAT/enhancer binding protein- (C/EBP ) and C/EBP , and the receptors for granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF (GM-CSF), consistent with their critical roles in granulopoiesis. Collectively, these observations suggest previously unknown physiologic roles for Fli-1 in granulocytic, erythroid, and NK cell proliferation and differentiation. Production of chimeras by morula-stage embryo aggregation is an effective way to unravel cell-autonomous hematopoietic defects in gene-targeted mice.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
A Fli in the ointment
- Ramesh A. Shivdasani
Blood 2005 105: 9-10.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
Y. Asano and M. Trojanowska
Phosphorylation of Fli1 at Threonine 312 by Protein Kinase C {delta} Promotes Its Interaction with p300/CREB-Binding Protein-Associated Factor and Subsequent Acetylation in Response to Transforming Growth Factor {beta}
Mol. Cell. Biol.,
April 1, 2009;
29(7):
1882 - 1894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Asano, M. Markiewicz, M. Kubo, G. Szalai, D. K. Watson, and M. Trojanowska
Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin
Mol. Cell. Biol.,
January 15, 2009;
29(2):
425 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bouilloux, G. Juban, N. Cohet, D. Buet, B. Guyot, W. Vainchenker, F. Louache, and F. Morle
EKLF restricts megakaryocytic differentiation at the benefit of erythrocytic differentiation
Blood,
August 1, 2008;
112(3):
576 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Asano, J. Czuwara, and M. Trojanowska
Transforming Growth Factor- Regulates DNA Binding Activity of Transcription Factor Fli1 by p300/CREB-binding Protein-associated Factor-dependent Acetylation
J. Biol. Chem.,
November 30, 2007;
282(48):
34672 - 34683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Nakerakanti, B. Kapanadze, M. Yamasaki, M. Markiewicz, and M. Trojanowska
Fli1 and Ets1 Have Distinct Roles in Connective Tissue Growth Factor/CCN2 Gene Regulation and Induction of the Profibrotic Gene Program
J. Biol. Chem.,
September 1, 2006;
281(35):
25259 - 25269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. van den Akker, S. Ano, H.-M. Shih, L.-C. Wang, M. Pironin, J. J. Palvimo, N. Kotaja, O. Kirsh, A. Dejean, and J. Ghysdael
FLI-1 Functionally Interacts with PIASx{alpha}, a Member of the PIAS E3 SUMO Ligase Family
J. Biol. Chem.,
November 11, 2005;
280(45):
38035 - 38046.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|